Lipin Jerome Leon MD is categorized under Pediatricians in Los Angeles, CA and active since 1950.
Lipin Jerome Leon MD was established in 1950, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pediatricians business, which does work in the B2C market, and is classified as a Pediatricians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jerome Leon Lipin at the company’s single location by writing to 8733 Beverly Boulevard # 301, Los Angeles, California CA 90048 or by phoning (310) 855-1112. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lipin Jerome Leon MD |
| Contact Person: | Jerome Leon Lipin |
| Address: | 8733 Beverly Boulevard # 301, Los Angeles, California 90048 |
| Phone Number: | (310) 855-1112 |
| Website Address: | glaucoma-institute.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1950 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pediatricians |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Lipin Jerome Leon MD was started in 1950 to provide professional Pediatricians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jerome Leon Lipin for inquiries that concern Lipin Jerome Leon MD by calling the company number (310) 855-1112, as your correspondence is most welcome. Additionally, the physical location of the single location of Lipin Jerome Leon MD can be found at the coordinates 34.076902,-118.38159 as well as the street address 8733 Beverly Boulevard # 301 in Los Angeles, California 90048.
For its online presence, you may visit Lipin Jerome Leon MD’s website at glaucoma-institute.com and engage with its social media outlets through on Twitter and on Facebook.